90 related articles for article (PubMed ID: 27266882)
1. Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma.
Tjioe KC; Tostes Oliveira D; Gavard J
Nutr Cancer; 2016 Jul; 68(5):838-47. PubMed ID: 27266882
[TBL] [Abstract][Full Text] [Related]
2. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma.
Hsia SM; Yu CC; Shih YH; Yuanchien Chen M; Wang TH; Huang YT; Shieh TM
Head Neck; 2016 Apr; 38 Suppl 1():E360-71. PubMed ID: 25580586
[TBL] [Abstract][Full Text] [Related]
4. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
5. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.
Wang L; Mosel AJ; Oakley GG; Peng A
Mol Cancer Ther; 2012 Nov; 11(11):2401-9. PubMed ID: 22973056
[TBL] [Abstract][Full Text] [Related]
6. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
7. Abrus agglutinin promotes irreparable DNA damage by triggering ROS generation followed by ATM-p73 mediated apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Das DN; Mukhopadhyay S; Maiti TK; Shanmugam MK; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Nov; 56(11):2400-2413. PubMed ID: 28543759
[TBL] [Abstract][Full Text] [Related]
8. Luteolin induces apoptosis in oral squamous cancer cells.
Yang SF; Yang WE; Chang HR; Chu SC; Hsieh YS
J Dent Res; 2008 Apr; 87(4):401-6. PubMed ID: 18362328
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
Kim DJ; Lee JH; Park HR; Choi YW
Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
[TBL] [Abstract][Full Text] [Related]
10. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
11. Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity.
Sugita Y; Takao K; Uesawa Y; Sakagami H
Anticancer Res; 2017 Nov; 37(11):5919-5924. PubMed ID: 29061770
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells.
Yamano Y; Shiiba M; Negoro K; Nakatani K; Kasamatsu A; Yamatoji M; Sakuma K; Ogoshi K; Iyoda M; Shinozuka K; Yokoe H; Wada T; Fujita S; Iwasawa S; Takiguchi Y; Tanzawa H; Uzawa K
Head Neck; 2011 Mar; 33(3):309-17. PubMed ID: 20848452
[TBL] [Abstract][Full Text] [Related]
13. The novel DNA alkylating agent BO-1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models.
Sanjiv K; Su TL; Suman S; Kakadiya R; Lai TC; Wang HY; Hsiao M; Lee TC
Int J Cancer; 2012 Mar; 130(6):1440-50. PubMed ID: 21500194
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression.
Xiao C; Wang L; Zhu L; Zhang C; Zhou J
Biochem Biophys Res Commun; 2014 Nov; 454(4):576-80. PubMed ID: 25450696
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
Chian S; Thapa R; Chi Z; Wang XJ; Tang X
Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
[TBL] [Abstract][Full Text] [Related]
16. Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.
Yasukawa M; Fujihara H; Fujimori H; Kawaguchi K; Yamada H; Nakayama R; Yamamoto N; Kishi Y; Hamada Y; Masutani M
Int J Mol Sci; 2016 Feb; 17(3):272. PubMed ID: 26927065
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
[TBL] [Abstract][Full Text] [Related]
19. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
[TBL] [Abstract][Full Text] [Related]
20. Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.
Ohnishi Y; Minamino Y; Kakudo K; Nozaki M
Oncol Rep; 2014 Aug; 32(2):780-6. PubMed ID: 24926885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
